2025 年組織診斷全球市場報告

預計未來幾年組織診斷的市場規模將快速成長。到 2029 年，這一數字將成長至 106.7 億美元，複合年成長率為 13.5%。預測期內的成長將歸因於個人化醫療的成長、液態切片的興起、人工智慧和機器學習的採用、遠端病理學的擴展以及微創技術。預測期內的主要趨勢包括數位病理學、人工智慧 (AI)、遠端病理學服務、多重染色和成像以及基因組資料整合。

預計未來幾年癌症發生率的上升將推動組織診斷市場的成長。當基因改變導致細胞不受控制地生長，破壞身體組織並形成腫塊（即腫瘤）時，癌症就開始了。基因突變、致癌物質、吸煙、肥胖、輻射和荷爾蒙等各種因素都會導致癌症的發展。隨著癌症患者數量的增加，對組織診斷等診斷程序的需求將會增加，這對於確定疾病的進展至關重要。例如，2024年2月，總部設在瑞士的聯合國機構世界衛生組織（WHO）預測，2050年將有超過3,500萬例癌症新病例，比2022年預計的2,000萬例增加77%。因此，癌症發生率的上升正在刺激組織診斷市場的擴張。

醫療保健支出的增加預計將推動組織診斷市場的成長。醫療保健支出是指一定時期內國家或個人在醫療保健服務、治療和產品上花費的總金額。這些支出將用於支援先進診斷技術、研究和醫療保健基礎設施（包括組織診斷）的開發、取得和利用。例如，2024年7月，美國非營利組織美國醫學會報告稱，2012年至2022年處方藥的複合年成長率最高，為4.7%，而醫院護理的複合年成長率為4.4%，醫生服務的複合年成長率為4.2%。醫療保健支出的增加將推動診斷技術的進步，從而促進組織診斷市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球組織診斷PESTEL分析（政治、社會、技術、環境、法律、促進因素、限制因素）
• 最終用途產業分析
• 全球組織診斷市場：成長率分析
• 全球組織診斷市場表現：規模與成長，2019 年至 2024 年
• 全球組織診斷市場預測：2024-2029 年及 2034 年規模與成長
• 全球組織診斷總目標市場 (TAM)

第6章 市場細分

• 全球組織診斷市場：依產品、效能和預測，2019-2024 年、2024-2029 年、2034 年
• 耗材
• 抗體
• 套件
• 試劑
• 探測
• 裝置
• 玻片染色系統
• 掃描器
• 組織處理系統
• 全球組織診斷市場（按技術、效能和預測）2019-2024 年、2024-2029 年、2034 年
• 免疫組織化學 (IHC)
• 原位雜合技術（ISH）
• 數位病理學和工作流程管理
• 特殊染色
• 全球組織診斷市場：依疾病、表現及預測，2019-2024 年、2024-2029 年、2034 年
• 乳癌
• 胃癌
• 淋巴瘤
• 攝護腺癌
• 非小細胞肺癌（NSCLC）
• 全球組織診斷市場依最終使用者、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 醫院
• 實驗室
• 製藥公司
• 受託研究機構
• 全球組織診斷市場：耗材細分、類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 切片穿刺針
• 玻片和蓋玻片
• 組織包埋材料
• 全球組織診斷市場：抗體細分、類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
• 一抗
• 二抗
• 單株抗體
• 多株抗體
• 全球組織診斷市場：套件細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 診斷套件
• 檢測試劑套件
• 染色試劑套件
• 全球組織診斷市場：試劑細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 穩定劑
• 染色試劑
• 抗原修復解決方案
• 全球組織診斷市場：探針細分、類型、效能和預測，2019-2024 年、2024-2029 年、2034 年
• 螢光探針
• 分子探針
• 雜合反應探針
• 全球組織診斷市場：設備細分、類型、效能與預測，2019-2024 年、2024-2029 年、2034 年
• 顯微鏡
• 組織微陣列儀
• 雷射捕獲晶粒儀
• 全球組織診斷市場：玻片染色系統的細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 自動染色設備
• 手動染色系統
• 全球組織診斷市場：掃描器細分市場、類型、效能和預測，2019-2024 年、2024-2029 年、2034 年
• 數位幻燈片掃描儀
• 全幻燈片成像系統
• 全球組織診斷市場：組織處理系統細分、類型、績效與預測，2019-2024 年、2024-2029 年、2034 年
• 組織處理裝置
• 嵌入式中心
• 切片機

第7章 區域和國家分析

• 全球組織診斷市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球組織診斷市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

• 組織診斷市場：競爭格局
• 組織診斷市場：公司簡介
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Merck KGaA
• BioGenex Laboratories
• Sakura Finetek Co. Ltd.
• Philips Healthcare NV
• Bio-Rad Laboratories
• Ventana Medical Systems Inc.
• Hologic Inc.
• Becton Dickinson and Company
• Sysmex Corporation
• Cell Signaling Technology Inc.
• Enzo Life Sciences Inc.
• Epitomics Inc.
• Fluidigm Corporation
• GE Healthcare Technologies Inc.
• Genomic Health Inc.

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029 年組織診斷市場：提供新機會的國家
• 2029 年組織診斷市場：細分市場將帶來新機會
• 組織診斷市場 2029：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第 36 章 附錄

Tissue diagnostic refers to a medical procedure that uses instruments to remove and stain tissue that must be sent to a laboratory or pathology department for documentation of what was excised for patient care (for tissue diagnostics). This offers measurements and descriptions, including any abnormalities, and an interpretation (or diagnosis) of health or disease status, under applicable legislation.

The main types of products in tissue diagnostic are consumables, antibodies, kits, reagents, probes, instrument, slide staining system, scanner and tissue processing system. The antibodies are used for the detection of infections, recognition of allergies, and the measurement of hormones and other biological markers in the blood in tissue diagnostics. The technologies used in tissue diagnostic are immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and workflow management and special staining to detect diseases such as breast cancer, gastric cancer, lymphoma, prostate cancer and non-small cell lung cancer (NSCLC). Tissue diagnostic is mostly used in hospitals, research laboratories, pharmaceutical companies, and contract research organizations.

The tissue diagnostic market research report is one of a series of new reports from The Business Research Company that provides tissue diagnostic market statistics, including tissue diagnostic industry global market size, regional shares, competitors with a tissue diagnostic market share, detailed tissue diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the tissue diagnostic industry. This tissue diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tissue diagnostic market size has grown rapidly in recent years. It will grow from $5.77 billion in 2024 to $6.44 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to aging population, cancer prevalence, technological advancements, increased disease awareness, pathology workflow efficiency

The tissue diagnostic market size is expected to see rapid growth in the next few years. It will grow to $10.67 billion in 2029 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to personalized medicine growth, rise of liquid biopsies, ai and machine learning adoption, telepathology expansion, minimally invasive techniques. Major trends in the forecast period include digital pathology, artificial intelligence (ai), telepathology services, multiplex staining and imaging, integration of genomic data.

The increasing incidence of cancer is expected to drive the growth of the tissue diagnostic market in the coming years. Cancer begins when genetic changes cause cells to grow uncontrollably, destroying body tissue and forming a mass known as a tumor, which can be either cancerous or benign. Various factors, including genetic mutations, carcinogens, smoking, obesity, radiation, and hormones, can lead to the development of cancer. As cancer cases rise, the demand for diagnostic procedures like tissue diagnostics will grow, as these are essential in determining the disease's progression. For example, in February 2024, the World Health Organization, a Switzerland-based United Nations agency, projected that new cancer cases would rise to over 35 million by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Thus, the rising cancer incidence is fueling the expansion of the tissue diagnostic market.

The increasing healthcare expenditure is expected to drive the growth of the tissue diagnostic market. Healthcare expenditure refers to the total amount of money spent on healthcare services, treatments, and products over a certain period, either at the national or individual level. This spending supports the development, accessibility, and utilization of advanced diagnostic technologies, research, and medical infrastructure, including tissue diagnostics. For example, in July 2024, the American Medical Association, a US-based nonprofit organization, reported that from 2012 to 2022, the average annual growth rate for prescription drugs was the highest at 4.7%, compared to 4.4% for hospital care and 4.2% for physician services. This increase in healthcare spending helps foster advancements in diagnostic technologies, driving the growth of the tissue diagnostic market.

Product innovation is a growing trend in the tissue diagnostic market, with companies introducing advanced products and solutions that can collect multiple sample types, test multiple samples simultaneously, automate lab operations, and make diagnostics more accessible. Leading players are focusing on developing automated tissue diagnostic systems to gain a competitive advantage and boost revenue. For instance, in June 2022, Roche, a Switzerland-based healthcare company, launched the BenchMark ULTRA PLUS system for cancer diagnostics. This tissue staining system features optimized workflow, enhanced testing efficiency, and sustainable environmental features, allowing pathologists to deliver high-quality, timely results to doctors and patients. Key innovations in the system include intuitive software, remote monitoring capabilities, an integrated touchscreen for a better user experience, and environmentally sustainable waste management and packaging.

The technological advancements, particularly the integration of artificial intelligence (AI), are influencing the tissue diagnostic market. AI is employed to analyze medical images and pathological data, enhancing the accuracy and efficiency of disease detection and classification. For instance, in 2023, Qritive introduced the Qai Prostate, an AI-powered prostate cancer detection tool, providing pathologists with advanced capabilities for detecting and classifying malignant and benign tumor locations in biopsy tissue samples. This integration of AI represents a strategic move to improve precision in cancer diagnosis and treatment within the tissue diagnostic market.

In February 2022, Labcorp's acquisition of Personal Genome Diagnostics (PGDx) for $575 million stands out. This move strengthens Labcorp's next-generation sequencing-based genomic profiling capabilities and enhances existing liquid biopsy capabilities, reflecting the industry's commitment to advancing cancer genomics.

Major companies operating in the tissue diagnostic market include F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies Inc., Merck KGaA, BioGenex Laboratories, Sakura Finetek Co. Ltd., Philips Healthcare NV, Bio-Rad Laboratories, Ventana Medical Systems Inc., Hologic Inc., Becton Dickinson and Company, Sysmex Corporation, Cell Signaling Technology Inc., Enzo Life Sciences Inc., Epitomics Inc., Fluidigm Corporation, GE Healthcare Technologies Inc., Genomic Health Inc., Illumina Inc., Leica Microsystems GmbH, Menarini Diagnostics S.r.l, Myriad Genetics Inc., NanoString Technologies Inc., PerkinElmer Inc., QIAGEN N.V., Siemens Healthineers AG, Zeiss Group AG, CytomX Therapeutics Inc.

North America was the largest region in the tissue diagnostic market in 2024. The regions covered in the global tissue diagnostic industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the tissue diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The tissue diagnostic market includes revenues earned by entities by consumables and instruments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tissue diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Consumables; Antibodies; Kits; Reagents; Probes; Instruments; Slide Staining System; Scanner; Tissue Processing system
• 2) By Technology: Immunohistochemistry (IHC); In Situ Hybridization (ISH); Digital Pathology And Workflow Management; Special Staining
• 3) By Disease: Breast Cancer; Gastric Cancer; Lymphoma; Prostate Cancer; Non-Small Cell Lung Cancer (NSCLC)
• 4) By End User: Hospitals; Research Laboratories; Pharmaceutical Companies; Contract Research Organizations
• Subsegments:
• 1) By Consumables: Biopsy Needles; Slides And Cover Slips; Tissue Embedding Materials
• 2) By Antibodies: Primary Antibodies; Secondary Antibodies; Monoclonal Antibodies; Polyclonal Antibodies
• 3) By Kits: Diagnostic Kits; Assay Kits; Staining Kits
• 4) By Reagents: Fixatives; Staining Reagents; Antigen Retrieval Solutions
• 5) By Probes: Fluorescent Probes; Molecular Probes; Hybridization Probes
• 6) By Instruments: Microscopes; Tissue Microarray Instruments; Laser Capture Microdissection Instruments
• 7) By Slide Staining System: Automated Stainers; Manual Staining Systems
• 8) By Scanner: Digital Slide Scanners; Whole Slide Imaging Systems
• 9) By Tissue Processing System: Tissue Processors; Embedding Centers; Microtomes
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Danaher Corporation; Thermo Fisher Scientific Inc.; Abbott Laboratories; Agilent Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tissue Diagnostic Market Characteristics

3. Tissue Diagnostic Market Trends And Strategies

4. Tissue Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Tissue Diagnostic Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tissue Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tissue Diagnostic Market Growth Rate Analysis
• 5.4. Global Tissue Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tissue Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tissue Diagnostic Total Addressable Market (TAM)

6. Tissue Diagnostic Market Segmentation

• 6.1. Global Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consumables
• Antibodies
• Kits
• Reagents
• Probes
• Instruments
• Slide Staining System
• Scanner
• Tissue Processing system
• 6.2. Global Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunohistochemistry (IHC)
• In Situ Hybridization (ISH)
• Digital Pathology And Workflow Management
• Special Staining
• 6.3. Global Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breast Cancer
• Gastric Cancer
• Lymphoma
• Prostate Cancer
• Non-Small Cell Lung Cancer (NSCLC)
• 6.4. Global Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Research Laboratories
• Pharmaceutical Companies
• Contract Research Organizations
• 6.5. Global Tissue Diagnostic Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopsy Needles
• Slides And Cover Slips
• Tissue Embedding Materials
• 6.6. Global Tissue Diagnostic Market, Sub-Segmentation Of Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Primary Antibodies
• Secondary Antibodies
• Monoclonal Antibodies
• Polyclonal Antibodies
• 6.7. Global Tissue Diagnostic Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Kits
• Assay Kits
• Staining Kits
• 6.8. Global Tissue Diagnostic Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fixatives
• Staining Reagents
• Antigen Retrieval Solutions
• 6.9. Global Tissue Diagnostic Market, Sub-Segmentation Of Probes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fluorescent Probes
• Molecular Probes
• Hybridization Probes
• 6.10. Global Tissue Diagnostic Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microscopes
• Tissue Microarray Instruments
• Laser Capture Microdissection Instruments
• 6.11. Global Tissue Diagnostic Market, Sub-Segmentation Of Slide Staining System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Stainers
• Manual Staining Systems
• 6.12. Global Tissue Diagnostic Market, Sub-Segmentation Of Scanner, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Digital Slide Scanners
• Whole Slide Imaging Systems
• 6.13. Global Tissue Diagnostic Market, Sub-Segmentation Of Tissue Processing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tissue Processors
• Embedding Centers
• Microtomes

7. Tissue Diagnostic Market Regional And Country Analysis

• 7.1. Global Tissue Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tissue Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tissue Diagnostic Market

• 8.1. Asia-Pacific Tissue Diagnostic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tissue Diagnostic Market

• 9.1. China Tissue Diagnostic Market Overview
• 9.2. China Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tissue Diagnostic Market

• 10.1. India Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tissue Diagnostic Market

• 11.1. Japan Tissue Diagnostic Market Overview
• 11.2. Japan Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tissue Diagnostic Market

• 12.1. Australia Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tissue Diagnostic Market

• 13.1. Indonesia Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tissue Diagnostic Market

• 14.1. South Korea Tissue Diagnostic Market Overview
• 14.2. South Korea Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tissue Diagnostic Market

• 15.1. Western Europe Tissue Diagnostic Market Overview
• 15.2. Western Europe Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tissue Diagnostic Market

• 16.1. UK Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tissue Diagnostic Market

• 17.1. Germany Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tissue Diagnostic Market

• 18.1. France Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tissue Diagnostic Market

• 19.1. Italy Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tissue Diagnostic Market

• 20.1. Spain Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tissue Diagnostic Market

• 21.1. Eastern Europe Tissue Diagnostic Market Overview
• 21.2. Eastern Europe Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tissue Diagnostic Market

• 22.1. Russia Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tissue Diagnostic Market

• 23.1. North America Tissue Diagnostic Market Overview
• 23.2. North America Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tissue Diagnostic Market

• 24.1. USA Tissue Diagnostic Market Overview
• 24.2. USA Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tissue Diagnostic Market

• 25.1. Canada Tissue Diagnostic Market Overview
• 25.2. Canada Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tissue Diagnostic Market

• 26.1. South America Tissue Diagnostic Market Overview
• 26.2. South America Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tissue Diagnostic Market

• 27.1. Brazil Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tissue Diagnostic Market

• 28.1. Middle East Tissue Diagnostic Market Overview
• 28.2. Middle East Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tissue Diagnostic Market

• 29.1. Africa Tissue Diagnostic Market Overview
• 29.2. Africa Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tissue Diagnostic Market Competitive Landscape And Company Profiles

• 30.1. Tissue Diagnostic Market Competitive Landscape
• 30.2. Tissue Diagnostic Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tissue Diagnostic Market Other Major And Innovative Companies

• 31.1. Merck KGaA
• 31.2. BioGenex Laboratories
• 31.3. Sakura Finetek Co. Ltd.
• 31.4. Philips Healthcare NV
• 31.5. Bio-Rad Laboratories
• 31.6. Ventana Medical Systems Inc.
• 31.7. Hologic Inc.
• 31.8. Becton Dickinson and Company
• 31.9. Sysmex Corporation
• 31.10. Cell Signaling Technology Inc.
• 31.11. Enzo Life Sciences Inc.
• 31.12. Epitomics Inc.
• 31.13. Fluidigm Corporation
• 31.14. GE Healthcare Technologies Inc.
• 31.15. Genomic Health Inc.

32. Global Tissue Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tissue Diagnostic Market

34. Recent Developments In The Tissue Diagnostic Market

35. Tissue Diagnostic Market High Potential Countries, Segments and Strategies

• 35.1 Tissue Diagnostic Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tissue Diagnostic Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tissue Diagnostic Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer